Germline Mutations in Predisposition Genes in Pediatric Cancer

Authors:

Abstract
Zhang et al. (Dec. 10 issue)1 report the prevalence of mutations in predisposition genes among children and adolescents with cancer. One of their main conclusions is that family history does not predict the presence of an underlying germline mutation. However, it is not clear how the authors obtained information about family history. There are important differences between an in-depth interview by a clinical geneticist and a query about additional cancer in the family by a pediatrician. Moreover, information on family history was available in only 58 patients (61%) and missing in the remaining 37 patients (39%); selection bias may have influenced the results. For example, in families in which many members have died from cancer at a young age, family contacts may be lost. Therefore, the next generation may not be aware of a family history of cancer and may not bring up the subject during consultation. Moreover, the authors’ conclusion does not hold true for all types of hereditary cancer — for example, cancer associated with TP53 germline mutations. At least 8 of the 50 patients with a TP53 germline mutation had a family history consistent with the Li–Fraumeni syndrome, and in the remaining 42 patients, it is unclear whether data on family history were available. The present study seems ill designed to test the predictive power (usefulness) of taking a family history for patients with a type of pediatric cancer that is known to have a heritable component.